GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alterity Therapeutics Ltd (ASX:ATH) » Definitions » E10

Alterity Therapeutics (ASX:ATH) E10 : A$0.00 (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Alterity Therapeutics E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Alterity Therapeutics's adjusted earnings per share data for the three months ended in Dec. 2023 was A$0.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is A$0.00 for the trailing ten years ended in Dec. 2023.

During the past 3 years, the average E10 Growth Rate was 9.10% per year. During the past 5 years, the average E10 Growth Rate was 10.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Alterity Therapeutics was 12.60% per year. The lowest was 3.50% per year. And the median was 8.40% per year.

As of today (2024-05-28), Alterity Therapeutics's current stock price is A$0.005. Alterity Therapeutics's E10 for the quarter that ended in Dec. 2023 was A$0.00. Alterity Therapeutics's Shiller PE Ratio of today is .


Alterity Therapeutics E10 Historical Data

The historical data trend for Alterity Therapeutics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alterity Therapeutics E10 Chart

Alterity Therapeutics Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.09 -0.08 -0.07 -0.06 -0.06

Alterity Therapeutics Quarterly Data
Jun18 Dec18 Jun19 Sep19 Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -0.06 - - -

Competitive Comparison of Alterity Therapeutics's E10

For the Biotechnology subindustry, Alterity Therapeutics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alterity Therapeutics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alterity Therapeutics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Alterity Therapeutics's Shiller PE Ratio falls into.



Alterity Therapeutics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Alterity Therapeutics's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0/126.3989*126.3989
=0.000

Current CPI (Dec. 2023) = 126.3989.

Alterity Therapeutics Quarterly Data

per share eps CPI Adj_EPS
200806 -0.077 85.071 -0.114
200812 -0.023 85.814 -0.034
200906 -0.017 86.278 -0.025
200912 -0.010 87.578 -0.014
201006 -0.012 88.971 -0.017
201012 -0.016 89.993 -0.022
201106 -0.010 92.129 -0.014
201112 -0.012 92.686 -0.016
201206 -0.006 93.244 -0.008
201212 -0.014 94.730 -0.019
201306 -0.009 95.473 -0.012
201312 -0.020 97.330 -0.026
201406 -0.011 98.352 -0.014
201412 -0.003 99.002 -0.004
201506 -0.009 99.838 -0.011
201509 0.000 100.302 0.000
201512 -0.005 100.673 -0.006
201606 -0.009 100.859 -0.011
201612 -0.007 102.159 -0.009
201706 -0.007 102.809 -0.009
201712 -0.007 104.110 -0.008
201806 -0.009 104.945 -0.011
201812 -0.010 105.967 -0.012
201906 -0.010 106.617 -0.012
201909 0.000 107.174 0.000
201912 -0.007 107.917 -0.008
202006 -0.009 106.246 -0.011
202012 -0.007 108.846 -0.008
202103 0.000 109.496 0.000
202106 -0.003 110.332 -0.003
202109 0.000 111.168 0.000
202112 -0.003 112.654 -0.003
202203 0.000 115.069 0.000
202206 -0.003 117.112 -0.003
202209 0.000 119.248 0.000
202212 -0.003 121.477 -0.003
202303 0.000 123.148 0.000
202306 -0.002 124.170 -0.002
202309 0.000 125.656 0.000
202312 0.000 126.399 0.000

Add all the adjusted EPS together and divide 10 will get our e10.


Alterity Therapeutics  (ASX:ATH) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Alterity Therapeutics E10 Related Terms

Thank you for viewing the detailed overview of Alterity Therapeutics's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Alterity Therapeutics (ASX:ATH) Business Description

Traded in Other Exchanges
Address
350 Collins Street, Level 14, Melbourne, VIC, AUS, 3000
Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders.